Global Hematologic Malignancies Detection Market Growth (Status and Outlook) 2026-2032

May 2026 | 109 pages | ID: G5AC435DBD16EN
LP Information

Abstracts

The global Hematologic Malignancies Detection market size is predicted to grow from US$ 3207 million in 2025 to US$ 8456 million in 2032; it is expected to grow at a CAGR of 15.1% from 2026 to 2032.

Hematological malignancy is a major disease that seriously endangers human health. With the invention and application of polymerase chain reaction, immunohistochemistry, next-generation sequencing and fluorescence in situ hybridization, its overall diagnostic level has been significantly improved.

Increasing prevalence of hematological malignancies, emerging new technologies and methods for testing, patient preference for testing treatments, and increasing regulation across the healthcare industry are the key factors driving the growth of hematological malignancies testing market revenue.

LPI (LP Information)' newest research report, the “Hematologic Malignancies Detection Industry Forecast” looks at past sales and reviews total world Hematologic Malignancies Detection sales in 2025, providing a comprehensive analysis by region and market sector of projected Hematologic Malignancies Detection sales for 2026 through 2032. With Hematologic Malignancies Detection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Hematologic Malignancies Detection industry.

This Insight Report provides a comprehensive analysis of the global Hematologic Malignancies Detection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Hematologic Malignancies Detection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Hematologic Malignancies Detection market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Hematologic Malignancies Detection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Hematologic Malignancies Detection.

This report presents a comprehensive overview, market shares, and growth opportunities of Hematologic Malignancies Detection market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Polymerase Chain Reaction
• Immunochemistry
• Next Generation Sequencing
• Fluorescence in Situ Hybridization
• Others

Segmentation by Application:

• Multiple Myeloma
• Myelodysplastic Syndrome
• Leukemia
• Myeloproliferative Neoplasms
• Lymphoma
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• ArcherDx
• Bio-Rad Laboratories
• sysmex
• Invitae
• NeoGenomics Laboratories
• Abbott Laboratories
• Cancer Genetics
• Adaptive Biotechnologies Corporation
• Asuragen
• Invivoscribe
• Nanjing Shihejiyin Technology
• Annaroad Gene Technology
• BGI Genomics

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Hematologic Malignancies Detection Market Size (2021-2032)
  2.1.2 Hematologic Malignancies Detection Market Size CAGR by Region (2021 VS 2025 VS 2032)
  2.1.3 World Current & Future Analysis for Hematologic Malignancies Detection by Country/Region (2021, 2025 & 2032)
2.2 Hematologic Malignancies Detection Segment by Type
  2.2.1 Polymerase Chain Reaction
  2.2.2 Immunochemistry
  2.2.3 Next Generation Sequencing
  2.2.4 Fluorescence in Situ Hybridization
  2.2.5 Others
  2.2.6 Hematologic Malignancies Detection Market Size by Type
    2.2.6.1 Hematologic Malignancies Detection Market Size CAGR by Type (2021 VS 2025 VS 2032)
    2.2.6.2 Global Hematologic Malignancies Detection Market Size Market Share by Type (2021-2026)
2.3 Hematologic Malignancies Detection Segment by Application
  2.3.1 Multiple Myeloma
  2.3.2 Myelodysplastic Syndrome
  2.3.3 Leukemia
  2.3.4 Myeloproliferative Neoplasms
  2.3.5 Lymphoma
  2.3.6 Others
  2.3.7 Hematologic Malignancies Detection Market Size by Application
    2.3.7.1 Hematologic Malignancies Detection Market Size CAGR by Application (2021 VS 2025 VS 2032)
    2.3.7.2 Global Hematologic Malignancies Detection Market Size Market Share by Application (2021-2026)

3 HEMATOLOGIC MALIGNANCIES DETECTION MARKET SIZE BY PLAYER

3.1 Hematologic Malignancies Detection Market Size Market Share by Player
  3.1.1 Global Hematologic Malignancies Detection Revenue by Player (2021-2026)
  3.1.2 Global Hematologic Malignancies Detection Revenue Market Share by Player (2021-2026)
3.2 Global Hematologic Malignancies Detection Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 HEMATOLOGIC MALIGNANCIES DETECTION BY REGION

4.1 Hematologic Malignancies Detection Market Size by Region (2021-2026)
4.2 Global Hematologic Malignancies Detection Annual Revenue by Country/Region (2021-2026)
4.3 Americas Hematologic Malignancies Detection Market Size Growth (2021-2026)
4.4 APAC Hematologic Malignancies Detection Market Size Growth (2021-2026)
4.5 Europe Hematologic Malignancies Detection Market Size Growth (2021-2026)
4.6 Middle East & Africa Hematologic Malignancies Detection Market Size Growth (2021-2026)

5 AMERICAS

5.1 Americas Hematologic Malignancies Detection Market Size by Country (2021-2026)
5.2 Americas Hematologic Malignancies Detection Market Size by Type (2021-2026)
5.3 Americas Hematologic Malignancies Detection Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Hematologic Malignancies Detection Market Size by Region (2021-2026)
6.2 APAC Hematologic Malignancies Detection Market Size by Type (2021-2026)
6.3 APAC Hematologic Malignancies Detection Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Hematologic Malignancies Detection Market Size by Country (2021-2026)
7.2 Europe Hematologic Malignancies Detection Market Size by Type (2021-2026)
7.3 Europe Hematologic Malignancies Detection Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Hematologic Malignancies Detection by Region (2021-2026)
8.2 Middle East & Africa Hematologic Malignancies Detection Market Size by Type (2021-2026)
8.3 Middle East & Africa Hematologic Malignancies Detection Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL HEMATOLOGIC MALIGNANCIES DETECTION MARKET FORECAST

10.1 Global Hematologic Malignancies Detection Forecast by Region (2027-2032)
  10.1.1 Global Hematologic Malignancies Detection Forecast by Region (2027-2032)
  10.1.2 Americas Hematologic Malignancies Detection Forecast
  10.1.3 APAC Hematologic Malignancies Detection Forecast
  10.1.4 Europe Hematologic Malignancies Detection Forecast
  10.1.5 Middle East & Africa Hematologic Malignancies Detection Forecast
10.2 Americas Hematologic Malignancies Detection Forecast by Country (2027-2032)
  10.2.1 United States Market Hematologic Malignancies Detection Forecast
  10.2.2 Canada Market Hematologic Malignancies Detection Forecast
  10.2.3 Mexico Market Hematologic Malignancies Detection Forecast
  10.2.4 Brazil Market Hematologic Malignancies Detection Forecast
10.3 APAC Hematologic Malignancies Detection Forecast by Region (2027-2032)
  10.3.1 China Hematologic Malignancies Detection Market Forecast
  10.3.2 Japan Market Hematologic Malignancies Detection Forecast
  10.3.3 Korea Market Hematologic Malignancies Detection Forecast
  10.3.4 Southeast Asia Market Hematologic Malignancies Detection Forecast
  10.3.5 India Market Hematologic Malignancies Detection Forecast
  10.3.6 Australia Market Hematologic Malignancies Detection Forecast
10.4 Europe Hematologic Malignancies Detection Forecast by Country (2027-2032)
  10.4.1 Germany Market Hematologic Malignancies Detection Forecast
  10.4.2 France Market Hematologic Malignancies Detection Forecast
  10.4.3 UK Market Hematologic Malignancies Detection Forecast
  10.4.4 Italy Market Hematologic Malignancies Detection Forecast
  10.4.5 Russia Market Hematologic Malignancies Detection Forecast
10.5 Middle East & Africa Hematologic Malignancies Detection Forecast by Region (2027-2032)
  10.5.1 Egypt Market Hematologic Malignancies Detection Forecast
  10.5.2 South Africa Market Hematologic Malignancies Detection Forecast
  10.5.3 Israel Market Hematologic Malignancies Detection Forecast
  10.5.4 Turkey Market Hematologic Malignancies Detection Forecast
10.6 Global Hematologic Malignancies Detection Forecast by Type (2027-2032)
10.7 Global Hematologic Malignancies Detection Forecast by Application (2027-2032)
  10.7.1 GCC Countries Market Hematologic Malignancies Detection Forecast

11 KEY PLAYERS ANALYSIS

11.1 ArcherDx
  11.1.1 ArcherDx Company Information
  11.1.2 ArcherDx Hematologic Malignancies Detection Product Offered
  11.1.3 ArcherDx Hematologic Malignancies Detection Revenue, Gross Margin and Market Share (2021-2026)
  11.1.4 ArcherDx Main Business Overview
  11.1.5 ArcherDx Latest Developments
11.2 Bio-Rad Laboratories
  11.2.1 Bio-Rad Laboratories Company Information
  11.2.2 Bio-Rad Laboratories Hematologic Malignancies Detection Product Offered
  11.2.3 Bio-Rad Laboratories Hematologic Malignancies Detection Revenue, Gross Margin and Market Share (2021-2026)
  11.2.4 Bio-Rad Laboratories Main Business Overview
  11.2.5 Bio-Rad Laboratories Latest Developments
11.3 sysmex
  11.3.1 sysmex Company Information
  11.3.2 sysmex Hematologic Malignancies Detection Product Offered
  11.3.3 sysmex Hematologic Malignancies Detection Revenue, Gross Margin and Market Share (2021-2026)
  11.3.4 sysmex Main Business Overview
  11.3.5 sysmex Latest Developments
11.4 Invitae
  11.4.1 Invitae Company Information
  11.4.2 Invitae Hematologic Malignancies Detection Product Offered
  11.4.3 Invitae Hematologic Malignancies Detection Revenue, Gross Margin and Market Share (2021-2026)
  11.4.4 Invitae Main Business Overview
  11.4.5 Invitae Latest Developments
11.5 NeoGenomics Laboratories
  11.5.1 NeoGenomics Laboratories Company Information
  11.5.2 NeoGenomics Laboratories Hematologic Malignancies Detection Product Offered
  11.5.3 NeoGenomics Laboratories Hematologic Malignancies Detection Revenue, Gross Margin and Market Share (2021-2026)
  11.5.4 NeoGenomics Laboratories Main Business Overview
  11.5.5 NeoGenomics Laboratories Latest Developments
11.6 Abbott Laboratories
  11.6.1 Abbott Laboratories Company Information
  11.6.2 Abbott Laboratories Hematologic Malignancies Detection Product Offered
  11.6.3 Abbott Laboratories Hematologic Malignancies Detection Revenue, Gross Margin and Market Share (2021-2026)
  11.6.4 Abbott Laboratories Main Business Overview
  11.6.5 Abbott Laboratories Latest Developments
11.7 Cancer Genetics
  11.7.1 Cancer Genetics Company Information
  11.7.2 Cancer Genetics Hematologic Malignancies Detection Product Offered
  11.7.3 Cancer Genetics Hematologic Malignancies Detection Revenue, Gross Margin and Market Share (2021-2026)
  11.7.4 Cancer Genetics Main Business Overview
  11.7.5 Cancer Genetics Latest Developments
11.8 Adaptive Biotechnologies Corporation
  11.8.1 Adaptive Biotechnologies Corporation Company Information
  11.8.2 Adaptive Biotechnologies Corporation Hematologic Malignancies Detection Product Offered
  11.8.3 Adaptive Biotechnologies Corporation Hematologic Malignancies Detection Revenue, Gross Margin and Market Share (2021-2026)
  11.8.4 Adaptive Biotechnologies Corporation Main Business Overview
  11.8.5 Adaptive Biotechnologies Corporation Latest Developments
11.9 Asuragen
  11.9.1 Asuragen Company Information
  11.9.2 Asuragen Hematologic Malignancies Detection Product Offered
  11.9.3 Asuragen Hematologic Malignancies Detection Revenue, Gross Margin and Market Share (2021-2026)
  11.9.4 Asuragen Main Business Overview
  11.9.5 Asuragen Latest Developments
11.10 Invivoscribe
  11.10.1 Invivoscribe Company Information
  11.10.2 Invivoscribe Hematologic Malignancies Detection Product Offered
  11.10.3 Invivoscribe Hematologic Malignancies Detection Revenue, Gross Margin and Market Share (2021-2026)
  11.10.4 Invivoscribe Main Business Overview
  11.10.5 Invivoscribe Latest Developments
11.11 Nanjing Shihejiyin Technology
  11.11.1 Nanjing Shihejiyin Technology Company Information
  11.11.2 Nanjing Shihejiyin Technology Hematologic Malignancies Detection Product Offered
  11.11.3 Nanjing Shihejiyin Technology Hematologic Malignancies Detection Revenue, Gross Margin and Market Share (2021-2026)
  11.11.4 Nanjing Shihejiyin Technology Main Business Overview
  11.11.5 Nanjing Shihejiyin Technology Latest Developments
11.12 Annaroad Gene Technology
  11.12.1 Annaroad Gene Technology Company Information
  11.12.2 Annaroad Gene Technology Hematologic Malignancies Detection Product Offered
  11.12.3 Annaroad Gene Technology Hematologic Malignancies Detection Revenue, Gross Margin and Market Share (2021-2026)
  11.12.4 Annaroad Gene Technology Main Business Overview
  11.12.5 Annaroad Gene Technology Latest Developments
11.13 BGI Genomics
  11.13.1 BGI Genomics Company Information
  11.13.2 BGI Genomics Hematologic Malignancies Detection Product Offered
  11.13.3 BGI Genomics Hematologic Malignancies Detection Revenue, Gross Margin and Market Share (2021-2026)
  11.13.4 BGI Genomics Main Business Overview
  11.13.5 BGI Genomics Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Hematologic Malignancies Detection Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Hematologic Malignancies Detection Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Polymerase Chain Reaction
Table 4. Major Players of Immunochemistry
Table 5. Major Players of Next Generation Sequencing
Table 6. Major Players of Fluorescence in Situ Hybridization
Table 7. Major Players of Others
Table 8. Hematologic Malignancies Detection Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global Hematologic Malignancies Detection Market Size by Type (2021-2026) & ($ millions)
Table 10. Global Hematologic Malignancies Detection Market Size Market Share by Type (2021-2026)
Table 11. Hematologic Malignancies Detection Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 12. Global Hematologic Malignancies Detection Market Size by Application (2021-2026) & ($ millions)
Table 13. Global Hematologic Malignancies Detection Market Size Market Share by Application (2021-2026)
Table 14. Global Hematologic Malignancies Detection Revenue by Player (2021-2026) & ($ millions)
Table 15. Global Hematologic Malignancies Detection Revenue Market Share by Player (2021-2026)
Table 16. Hematologic Malignancies Detection Key Players Head office and Products Offered
Table 17. Hematologic Malignancies Detection Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 18. New Products and Potential Entrants
Table 19. Mergers & Acquisitions, Expansion
Table 20. Global Hematologic Malignancies Detection Market Size by Region (2021-2026) & ($ millions)
Table 21. Global Hematologic Malignancies Detection Market Size Market Share by Region (2021-2026)
Table 22. Global Hematologic Malignancies Detection Revenue by Country/Region (2021-2026) & ($ millions)
Table 23. Global Hematologic Malignancies Detection Revenue Market Share by Country/Region (2021-2026)
Table 24. Americas Hematologic Malignancies Detection Market Size by Country (2021-2026) & ($ millions)
Table 25. Americas Hematologic Malignancies Detection Market Size Market Share by Country (2021-2026)
Table 26. Americas Hematologic Malignancies Detection Market Size by Type (2021-2026) & ($ millions)
Table 27. Americas Hematologic Malignancies Detection Market Size Market Share by Type (2021-2026)
Table 28. Americas Hematologic Malignancies Detection Market Size by Application (2021-2026) & ($ millions)
Table 29. Americas Hematologic Malignancies Detection Market Size Market Share by Application (2021-2026)
Table 30. APAC Hematologic Malignancies Detection Market Size by Region (2021-2026) & ($ millions)
Table 31. APAC Hematologic Malignancies Detection Market Size Market Share by Region (2021-2026)
Table 32. APAC Hematologic Malignancies Detection Market Size by Type (2021-2026) & ($ millions)
Table 33. APAC Hematologic Malignancies Detection Market Size by Application (2021-2026) & ($ millions)
Table 34. Europe Hematologic Malignancies Detection Market Size by Country (2021-2026) & ($ millions)
Table 35. Europe Hematologic Malignancies Detection Market Size Market Share by Country (2021-2026)
Table 36. Europe Hematologic Malignancies Detection Market Size by Type (2021-2026) & ($ millions)
Table 37. Europe Hematologic Malignancies Detection Market Size by Application (2021-2026) & ($ millions)
Table 38. Middle East & Africa Hematologic Malignancies Detection Market Size by Region (2021-2026) & ($ millions)
Table 39. Middle East & Africa Hematologic Malignancies Detection Market Size by Type (2021-2026) & ($ millions)
Table 40. Middle East & Africa Hematologic Malignancies Detection Market Size by Application (2021-2026) & ($ millions)
Table 41. Key Market Drivers & Growth Opportunities of Hematologic Malignancies Detection
Table 42. Key Market Challenges & Risks of Hematologic Malignancies Detection
Table 43. Key Industry Trends of Hematologic Malignancies Detection
Table 44. Global Hematologic Malignancies Detection Market Size Forecast by Region (2027-2032) & ($ millions)
Table 45. Global Hematologic Malignancies Detection Market Size Market Share Forecast by Region (2027-2032)
Table 46. Global Hematologic Malignancies Detection Market Size Forecast by Type (2027-2032) & ($ millions)
Table 47. Global Hematologic Malignancies Detection Market Size Forecast by Application (2027-2032) & ($ millions)
Table 48. ArcherDx Details, Company Type, Hematologic Malignancies Detection Area Served and Its Competitors
Table 49. ArcherDx Hematologic Malignancies Detection Product Offered
Table 50. ArcherDx Hematologic Malignancies Detection Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 51. ArcherDx Main Business
Table 52. ArcherDx Latest Developments
Table 53. Bio-Rad Laboratories Details, Company Type, Hematologic Malignancies Detection Area Served and Its Competitors
Table 54. Bio-Rad Laboratories Hematologic Malignancies Detection Product Offered
Table 55. Bio-Rad Laboratories Hematologic Malignancies Detection Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 56. Bio-Rad Laboratories Main Business
Table 57. Bio-Rad Laboratories Latest Developments
Table 58. sysmex Details, Company Type, Hematologic Malignancies Detection Area Served and Its Competitors
Table 59. sysmex Hematologic Malignancies Detection Product Offered
Table 60. sysmex Hematologic Malignancies Detection Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 61. sysmex Main Business
Table 62. sysmex Latest Developments
Table 63. Invitae Details, Company Type, Hematologic Malignancies Detection Area Served and Its Competitors
Table 64. Invitae Hematologic Malignancies Detection Product Offered
Table 65. Invitae Hematologic Malignancies Detection Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 66. Invitae Main Business
Table 67. Invitae Latest Developments
Table 68. NeoGenomics Laboratories Details, Company Type, Hematologic Malignancies Detection Area Served and Its Competitors
Table 69. NeoGenomics Laboratories Hematologic Malignancies Detection Product Offered
Table 70. NeoGenomics Laboratories Hematologic Malignancies Detection Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 71. NeoGenomics Laboratories Main Business
Table 72. NeoGenomics Laboratories Latest Developments
Table 73. Abbott Laboratories Details, Company Type, Hematologic Malignancies Detection Area Served and Its Competitors
Table 74. Abbott Laboratories Hematologic Malignancies Detection Product Offered
Table 75. Abbott Laboratories Hematologic Malignancies Detection Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 76. Abbott Laboratories Main Business
Table 77. Abbott Laboratories Latest Developments
Table 78. Cancer Genetics Details, Company Type, Hematologic Malignancies Detection Area Served and Its Competitors
Table 79. Cancer Genetics Hematologic Malignancies Detection Product Offered
Table 80. Cancer Genetics Hematologic Malignancies Detection Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 81. Cancer Genetics Main Business
Table 82. Cancer Genetics Latest Developments
Table 83. Adaptive Biotechnologies Corporation Details, Company Type, Hematologic Malignancies Detection Area Served and Its Competitors
Table 84. Adaptive Biotechnologies Corporation Hematologic Malignancies Detection Product Offered
Table 85. Adaptive Biotechnologies Corporation Hematologic Malignancies Detection Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 86. Adaptive Biotechnologies Corporation Main Business
Table 87. Adaptive Biotechnologies Corporation Latest Developments
Table 88. Asuragen Details, Company Type, Hematologic Malignancies Detection Area Served and Its Competitors
Table 89. Asuragen Hematologic Malignancies Detection Product Offered
Table 90. Asuragen Hematologic Malignancies Detection Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 91. Asuragen Main Business
Table 92. Asuragen Latest Developments
Table 93. Invivoscribe Details, Company Type, Hematologic Malignancies Detection Area Served and Its Competitors
Table 94. Invivoscribe Hematologic Malignancies Detection Product Offered
Table 95. Invivoscribe Hematologic Malignancies Detection Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 96. Invivoscribe Main Business
Table 97. Invivoscribe Latest Developments
Table 98. Nanjing Shihejiyin Technology Details, Company Type, Hematologic Malignancies Detection Area Served and Its Competitors
Table 99. Nanjing Shihejiyin Technology Hematologic Malignancies Detection Product Offered
Table 100. Nanjing Shihejiyin Technology Hematologic Malignancies Detection Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 101. Nanjing Shihejiyin Technology Main Business
Table 102. Nanjing Shihejiyin Technology Latest Developments
Table 103. Annaroad Gene Technology Details, Company Type, Hematologic Malignancies Detection Area Served and Its Competitors
Table 104. Annaroad Gene Technology Hematologic Malignancies Detection Product Offered
Table 105. Annaroad Gene Technology Hematologic Malignancies Detection Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 106. Annaroad Gene Technology Main Business
Table 107. Annaroad Gene Technology Latest Developments
Table 108. BGI Genomics Details, Company Type, Hematologic Malignancies Detection Area Served and Its Competitors
Table 109. BGI Genomics Hematologic Malignancies Detection Product Offered
Table 110. BGI Genomics Hematologic Malignancies Detection Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 111. BGI Genomics Main Business
Table 112. BGI Genomics Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Hematologic Malignancies Detection Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Hematologic Malignancies Detection Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Hematologic Malignancies Detection Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Hematologic Malignancies Detection Sales Market Share by Country/Region (2025)
Figure 8. Hematologic Malignancies Detection Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Hematologic Malignancies Detection Market Size Market Share by Type in 2025
Figure 10. Hematologic Malignancies Detection in Multiple Myeloma
Figure 11. Global Hematologic Malignancies Detection Market: Multiple Myeloma (2021-2026) & ($ millions)
Figure 12. Hematologic Malignancies Detection in Myelodysplastic Syndrome
Figure 13. Global Hematologic Malignancies Detection Market: Myelodysplastic Syndrome (2021-2026) & ($ millions)
Figure 14. Hematologic Malignancies Detection in Leukemia
Figure 15. Global Hematologic Malignancies Detection Market: Leukemia (2021-2026) & ($ millions)
Figure 16. Hematologic Malignancies Detection in Myeloproliferative Neoplasms
Figure 17. Global Hematologic Malignancies Detection Market: Myeloproliferative Neoplasms (2021-2026) & ($ millions)
Figure 18. Hematologic Malignancies Detection in Lymphoma
Figure 19. Global Hematologic Malignancies Detection Market: Lymphoma (2021-2026) & ($ millions)
Figure 20. Hematologic Malignancies Detection in Others
Figure 21. Global Hematologic Malignancies Detection Market: Others (2021-2026) & ($ millions)
Figure 22. Global Hematologic Malignancies Detection Market Size Market Share by Application in 2025
Figure 23. Global Hematologic Malignancies Detection Revenue Market Share by Player in 2025
Figure 24. Global Hematologic Malignancies Detection Market Size Market Share by Region (2021-2026)
Figure 25. Americas Hematologic Malignancies Detection Market Size 2021-2026 ($ millions)
Figure 26. APAC Hematologic Malignancies Detection Market Size 2021-2026 ($ millions)
Figure 27. Europe Hematologic Malignancies Detection Market Size 2021-2026 ($ millions)
Figure 28. Middle East & Africa Hematologic Malignancies Detection Market Size 2021-2026 ($ millions)
Figure 29. Americas Hematologic Malignancies Detection Value Market Share by Country in 2025
Figure 30. United States Hematologic Malignancies Detection Market Size Growth 2021-2026 ($ millions)
Figure 31. Canada Hematologic Malignancies Detection Market Size Growth 2021-2026 ($ millions)
Figure 32. Mexico Hematologic Malignancies Detection Market Size Growth 2021-2026 ($ millions)
Figure 33. Brazil Hematologic Malignancies Detection Market Size Growth 2021-2026 ($ millions)
Figure 34. APAC Hematologic Malignancies Detection Market Size Market Share by Region in 2025
Figure 35. APAC Hematologic Malignancies Detection Market Size Market Share by Type (2021-2026)
Figure 36. APAC Hematologic Malignancies Detection Market Size Market Share by Application (2021-2026)
Figure 37. China Hematologic Malignancies Detection Market Size Growth 2021-2026 ($ millions)
Figure 38. Japan Hematologic Malignancies Detection Market Size Growth 2021-2026 ($ millions)
Figure 39. South Korea Hematologic Malignancies Detection Market Size Growth 2021-2026 ($ millions)
Figure 40. Southeast Asia Hematologic Malignancies Detection Market Size Growth 2021-2026 ($ millions)
Figure 41. India Hematologic Malignancies Detection Market Size Growth 2021-2026 ($ millions)
Figure 42. Australia Hematologic Malignancies Detection Market Size Growth 2021-2026 ($ millions)
Figure 43. Europe Hematologic Malignancies Detection Market Size Market Share by Country in 2025
Figure 44. Europe Hematologic Malignancies Detection Market Size Market Share by Type (2021-2026)
Figure 45. Europe Hematologic Malignancies Detection Market Size Market Share by Application (2021-2026)
Figure 46. Germany Hematologic Malignancies Detection Market Size Growth 2021-2026 ($ millions)
Figure 47. France Hematologic Malignancies Detection Market Size Growth 2021-2026 ($ millions)
Figure 48. UK Hematologic Malignancies Detection Market Size Growth 2021-2026 ($ millions)
Figure 49. Italy Hematologic Malignancies Detection Market Size Growth 2021-2026 ($ millions)
Figure 50. Russia Hematologic Malignancies Detection Market Size Growth 2021-2026 ($ millions)
Figure 51. Middle East & Africa Hematologic Malignancies Detection Market Size Market Share by Region (2021-2026)
Figure 52. Middle East & Africa Hematologic Malignancies Detection Market Size Market Share by Type (2021-2026)
Figure 53. Middle East & Africa Hematologic Malignancies Detection Market Size Market Share by Application (2021-2026)
Figure 54. Egypt Hematologic Malignancies Detection Market Size Growth 2021-2026 ($ millions)
Figure 55. South Africa Hematologic Malignancies Detection Market Size Growth 2021-2026 ($ millions)
Figure 56. Israel Hematologic Malignancies Detection Market Size Growth 2021-2026 ($ millions)
Figure 57. Turkey Hematologic Malignancies Detection Market Size Growth 2021-2026 ($ millions)
Figure 58. GCC Countries Hematologic Malignancies Detection Market Size Growth 2021-2026 ($ millions)
Figure 59. Americas Hematologic Malignancies Detection Market Size 2027-2032 ($ millions)
Figure 60. APAC Hematologic Malignancies Detection Market Size 2027-2032 ($ millions)
Figure 61. Europe Hematologic Malignancies Detection Market Size 2027-2032 ($ millions)
Figure 62. Middle East & Africa Hematologic Malignancies Detection Market Size 2027-2032 ($ millions)
Figure 63. United States Hematologic Malignancies Detection Market Size 2027-2032 ($ millions)
Figure 64. Canada Hematologic Malignancies Detection Market Size 2027-2032 ($ millions)
Figure 65. Mexico Hematologic Malignancies Detection Market Size 2027-2032 ($ millions)
Figure 66. Brazil Hematologic Malignancies Detection Market Size 2027-2032 ($ millions)
Figure 67. China Hematologic Malignancies Detection Market Size 2027-2032 ($ millions)
Figure 68. Japan Hematologic Malignancies Detection Market Size 2027-2032 ($ millions)
Figure 69. Korea Hematologic Malignancies Detection Market Size 2027-2032 ($ millions)
Figure 70. Southeast Asia Hematologic Malignancies Detection Market Size 2027-2032 ($ millions)
Figure 71. India Hematologic Malignancies Detection Market Size 2027-2032 ($ millions)
Figure 72. Australia Hematologic Malignancies Detection Market Size 2027-2032 ($ millions)
Figure 73. Germany Hematologic Malignancies Detection Market Size 2027-2032 ($ millions)
Figure 74. France Hematologic Malignancies Detection Market Size 2027-2032 ($ millions)
Figure 75. UK Hematologic Malignancies Detection Market Size 2027-2032 ($ millions)
Figure 76. Italy Hematologic Malignancies Detection Market Size 2027-2032 ($ millions)
Figure 77. Russia Hematologic Malignancies Detection Market Size 2027-2032 ($ millions)
Figure 78. Egypt Hematologic Malignancies Detection Market Size 2027-2032 ($ millions)
Figure 79. South Africa Hematologic Malignancies Detection Market Size 2027-2032 ($ millions)
Figure 80. Israel Hematologic Malignancies Detection Market Size 2027-2032 ($ millions)
Figure 81. Turkey Hematologic Malignancies Detection Market Size 2027-2032 ($ millions)
Figure 82. Global Hematologic Malignancies Detection Market Size Market Share Forecast by Type (2027-2032)
Figure 83. Global Hematologic Malignancies Detection Market Size Market Share Forecast by Application (2027-2032)
Figure 84. GCC Countries Hematologic Malignancies Detection Market Size 2027-2032 ($ millions)